Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Rebound Therapeutics Corporation currently manages 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. This portfolio is distributed across 2 distinct art units, reflecting a focused range of medical and mechanical innovations. The prosecution involves 2 distinct examiners, which suggests that the company must navigate multiple examination styles to secure its patent rights.
The busiest examiner for this portfolio is NEAL, TIMOTHY JAY, who is currently managing 1 pending office action. Since there are 2 distinct examiners for 2 pending office actions, the workload is split, and no single examiner has a larger share of the workload than the other. This requires the company to maintain separate lines of communication within the Medical Devices & Mechanical Engineering field to move its current applications forward.
The involvement of 2 distinct art units indicates that the company's 2 pending office actions cover different technical classifications. Practitioners must be prepared to address the specific requirements of both NEAL, TIMOTHY JAY and the other assigned examiner. This focused portfolio allows for a high degree of attention to each of the 2 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NEAL, TIMOTHY JAY | 1 | 78.0% | +13.2% |
| HOAG, MITCHELL BRAIN | 1 | 70.3% | +19.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19298714 | Cannula and Obturator with a Transparent Tip with an Opaque Component | NEAL, TIMOTHY JAY | — |
| 19289561 | Cautery Tool For Intracranial Surgery | HOAG, MITCHELL BRAIN | — |
| Art Unit | Apps |
|---|---|
| 3795 | 1 |
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19298714 | Cannula and Obturator with a Transparent Tip with an Opaque Component | NEAL, TIMOTHY JAY | 3795 | DP | Non-Final OA | — | Pending | Aug 13, 2025 |
| 19289561 | Cautery Tool For Intracranial Surgery | HOAG, MITCHELL BRAIN | 3771 | §103 | Final Rejection | — | Pending | Aug 04, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRebound Therapeutics Corporation has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Timothy Jay Neal has the most, with 1 of Rebound Therapeutics Corporation's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
